Cell therapy, 3D culture systems and tissue engineering for cardiac regeneration

Advanced Drug Delivery Reviews

Volumn 69-70, Issue , 2014, Pages 254-269

  Emmert, Maximilian Y ^a,b,c   Hitchcock, Robert W ^d   Hoerstrup, Simon P ^a,b,c  

^a Swiss Center for Regenerative Medicine   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d Department of Electrical and Computer Engineering   (United States)

Author keywords

Bioreactors; Cardiac cell therapy; Cardiac tissue engineering; Myocardial regeneration; Stem cells; Three dimensional culture systems

Indexed keywords

BIOREACTORS; CYTOLOGY; HEART; STEM CELLS; THREE DIMENSIONAL; TISSUE ENGINEERING;

CARDIAC CELL; CARDIAC TISSUE ENGINEERING; FUTURE RESEARCH DIRECTIONS; ISCHEMIC HEART DISEASE; MYOCARDIAL REGENERATION; REGENERATIVE MEDICINE; THREE-DIMENSIONAL CULTURE; THREE-DIMENSIONAL CULTURE SYSTEM;

CELL ENGINEERING;

BIOMATERIAL;

ADIPOSE TISSUE CELL; ADIPOSE TISSUE DERIVED STEM CELL; BIOREACTOR; BONE MARROW CELL; CARDIAC REGENERATION; CARDIAC STEM CELL; CELL CULTURE; CELL THERAPY; CELL TYPE; CLINICAL RESEARCH; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; HEART FAILURE; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; HUMAN; INTRACARDIAC PATCH; ISCHEMIC HEART DISEASE; MESENCHYMAL STEM CELL; MYOBLAST; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SCAFFOLD FREE THREE DIMENSIONAL MICROTISSUE; THREE DIMENSIONAL CULTURE SYSTEM; TISSUE ENGINEERING; TISSUE REGENERATION; ANIMAL; BIOLOGICAL THERAPY; HEART; MYOCARDIAL ISCHEMIA; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; REGENERATION; REGENERATIVE MEDICINE; TRENDS;

ANIMALS; CELL- AND TISSUE-BASED THERAPY; HEART; HUMANS; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; REGENERATION; REGENERATIVE MEDICINE; TISSUE ENGINEERING;

EID: 84899990095     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2013.12.004     Document Type: Review

References (215)

1. Lloyd-Jones D., Adams R.J., Brown T.M., Carnethon M., Dai S., De Simone G., Ferguson T.B., Ford E., Furie K., Gillespie C., Go A., Greenlund K., Haase N., Hailpern S., Ho P.M., Howard V., Kissela B., Kittner S., Lackland D., Lisabeth L., Marelli A., McDermott M.M., Meigs J., Mozaffarian D., Mussolino M., Nichol G., Roger V.L., Rosamond W., Sacco R., Sorlie P., Thom T., Wasserthiel-Smoller S., Wong N.D., Wylie-Rosett J. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010, 121:e46-e215.
2. Jessup M., Brozena S. Heart failure. N. Engl. J. Med. 2003, 348:2007-2018.
3. Olson E.N. A decade of discoveries in cardiac biology. Nat. Med. 2004, 10:467-474.
4. Vunjak-Novakovic G., Lui K.O., Tandon N., Chien K.R. Bioengineering heart muscle: a paradigm for regenerative medicine. Annu. Rev. Biomed. Eng. 2011, 15:245-267.
5. Menasche P. Cardiac cell therapy: lessons from clinical trials. J. Mol. Cell. Cardiol. 2010, 50:258-265.
6. Abdel-Latif A., Bolli R., Tleyjeh I.M., Montori V.M., Perin E.C., Hornung C.A., Zuba-Surma E.K., Al-Mallah M., Dawn B. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch. Intern. Med. 2007, 167:989-997.
7. Menasché P. Cardiac cell therapy: lessons from clinical trials. J. Mol. Cell. Cardiol. 2011, 50:258-265.
8. Perez-Ilzarbe M., Agbulut O., Pelacho B., Ciorba C., Jose-Eneriz E.S., Desnos M., Hagège A.A., Aranda P., Andreu E.J., Menasché P. Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium. Eur. J. Heart Fail. 2008, 10:1065-1072.
9. Gnecchi M., He H., Noiseux N., Liang O.D., Zhang L., Morello F., Mu H., Melo L.G., Pratt R.E., Ingwall J.S. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 2006, 20:661-669.
10. Timmers L., Lim S.K., Arslan F., Armstrong J.S., Hoefer I.E., Doevendans P.A., Piek J.J., El Oakley R.M., Choo A., Lee C.N. Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res. 2008, 1:129-137.
11. Vunjak-Novakovic G., Tandon N., Godier A., Maidhof R., Marsano A., Martens T.P., Radisic M. Challenges in cardiac tissue engineering. Tissue Eng. Part B Rev. 2010, 16:169-187.
12. Elliott N.T., Yuan F. A review of three-dimensional in vitro tissue models for drug discovery and transport studies. J. Pharm. Sci. 2011, 100:59-74.
13. Bursac N., Papadaki M., Cohen R.J., Schoen F.J., Eisenberg S.R., Carrier R., Vunjak-Novakovic G., Freed L.E. Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. Am. J. Physiol. 1999, 277:433-444.
14. Carrier R.L., Rupnick M., Langer R., Schoen F.J., Freed L.E., Vunjak-Novakovic G. Perfusion improves tissue architecture of engineered cardiac muscle. Tissue Eng. 2002, 8:175-188.
15. Bursac N., Papadaki M., White J.A., Eisenberg S.R., Vunjak-Novakovic G., Freed L.E. Cultivation in rotating bioreactors promotes maintenance of cardiac myocyte electrophysiology and molecular properties. Tissue Eng. 2003, 9:1243-1253.
16. Carrier R.L., Papadaki M., Rupnick M., Schoen F.J., Bursac N., Langer R., Freed L.E., Vunjak-Novakovic G. Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol. Bioeng. 1999, 64:580-589.
17. van Luyn M.J.A., Tio R.A., Gallego y van Seijen X.J., Plantinga J.A., de Leij L., DeJongste M.J.L., van Wachem P.B. Cardiac tissue engineering: characteristics of in unison contracting two- and three-dimensional neonatal rat ventricle cell (co)-cultures. Biomaterials 2002, 23:4793-4801.
18. Akins R.E., Boyce R.A., Madonna M.L., Schroedl N.A., Gonda S.R., McLaughlin T.A., Hartzell C.R. Cardiac organogenesis in vitro: reestablishment of three-dimensional tissue architecture by dissociated neonatal rat ventricular cells. Tissue Eng. 1999, 5:103-118.
19. Lichtenberg A., Dumlu G., Walles T., Maringka M., Ringes-Lichtenberg S., Ruhparwar A., Mertsching H., Haverich A. A multifunctional bioreactor for three-dimensional cell (co)-culture. Biomaterials 2005, 26:555-562.
20. Radisic M., Marsano A., Maidhof R., Wang Y., Vunjak-Novakovic G. Cardiac tissue engineering using perfusion bioreactor systems. Nat. Protoc. 2008, 3:719-738.
21. Radisic M., Park H., Chen F., Salazar-Lazzaro J.E., Wang Y., Dennis R., Langer R., Freed L.E., Vunjak-Novakovic G. Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. Tissue Eng. 2006, 12:2077-2091.
22. Segers V.F., Lee R.T. Stem-cell therapy for cardiac disease. Nature 2008, 451:937-942.
23. Wei F., Wang T., Liu J., Du Y., Ma A. The subpopulation of mesenchymal stem cells that differentiate toward cardiomyocytes is cardiac progenitor cells. Exp. Cell Res. Nov. 1 2011, 317(18):2661-2670.
24. Jeevanantham V., Butler M., Saad A., Abdel-Latif A., Zuba-Surma E.K., Dawn B. Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation 2012, 126:551-568.
25. Francis D.P., Mielewczik M., Zargaran D., Cole G.D. Autologous bone marrow-derived stem cell therapy in heart disease: discrepancies and contradictions. Int. J. Cardiol. 2013, 168:3381-3403.
26. Williams A.R., Hare J.M. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ. Res. 2011, 109:923-940.
27. Emmert M.Y., Weber B., Wolint P., Frauenfelder T., Zeisberger S.M., Behr L., Sammut S., Scherman J., Brokopp C.E., Schwartlander R., Vogel V., Vogt P., Grunenfelder J., Alkadhi H., Falk V., Boss A., Hoerstrup S.P. Intramyocardial transplantation and tracking of human mesenchymal stem cells in a novel intra-uterine pre-immune fetal sheep myocardial infarction model: a proof of concept study. PLoS One 2013, 8:e57759.
28. Schuleri K.H., Boyle A.J., Centola M., Amado L.C., Evers R., Zimmet J.M., Evers K.S., Ostbye K.M., Scorpio D.G., Hare J.M., Lardo A.C. The adult Gottingen minipig as a model for chronic heart failure after myocardial infarction: focus on cardiovascular imaging and regenerative therapies. Comp. Med. 2008, 58:568-579.
29. Schuleri K.H., Centola M., Choi S.H., Evers K.S., Dawoud F., George R.T., Lima J.A., Lardo A.C. CT for evaluation of myocardial cell therapy in heart failure: a comparison with CMR imaging. JACC Cardiovasc. Imaging 2011, 4:1284-1293.
30. Schuleri K.H., Feigenbaum G.S., Centola M., Weiss E.S., Zimmet J.M., Turney J., Kellner J., Zviman M.M., Hatzistergos K.E., Detrick B., Conte J.V., McNiece I., Steenbergen C., Lardo A.C., Hare J.M. Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. Eur. Heart J. 2009, 30:2722-2732.
31. Hare J.M., Traverse J.H., Henry T.D., Dib N., Strumpf R.K., Schulman S.P., Gerstenblith G., DeMaria A.N., Denktas A.E., Gammon R.S., Hermiller J.B., Reisman M.A., Schaer G.L., Sherman W. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 2009, 54:2277-2286.
32. Williams A.R., Trachtenberg B., Velazquez D.L., McNiece I., Altman P., Rouy D., Mendizabal A.M., Pattany P.M., Lopera G.A., Fishman J., Zambrano J.P., Heldman A.W., Hare J.M. Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling. Circ. Res. 2011, 108:792-796.
33. Behfar A., Yamada S., Crespo-Diaz R., Nesbitt J.J., Rowe L.A., Perez-Terzic C., Gaussin V., Homsy C., Bartunek J., Terzic A. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J. Am. Coll. Cardiol. 2010, 56:721-734.
34. Zhu Y., Liu T., Song K., Jiang B., Ma X., Cui Z. Collagen-chitosan polymer as a scaffold for the proliferation of human adipose tissue-derived stem cells. J. Mater. Sci. Mater. Med. 2009, 20:799-808.
35. Valina C., Pinkernell K., Song Y.H., Bai X., Sadat S., Campeau R.J., Le Jemtel T.H., Alt E. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur. Heart J. 2007, 28:2667-2677.
36. Kawamoto A., Iwasaki H., Kusano K., Murayama T., Oyamada A., Silver M., Hulbert C., Gavin M., Hanley A., Ma H., Kearney M., Zak V., Asahara T., Losordo D.W. CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation 2006, 114:2163-2169.
37. Losordo D.W., Schatz R.A., White C.J., Udelson J.E., Veereshwarayya V., Durgin M., Poh K.K., Weinstein R., Kearney M., Chaudhry M., Burg A., Eaton L., Heyd L., Thorne T., Shturman L., Hoffmeister P., Story K., Zak V., Dowling D., Traverse J.H., Olson R.E., Flanagan J., Sodano D., Murayama T., Kawamoto A., Kusano K.F., Wollins J., Welt F., Shah P., Soukas P., Asahara T., Henry T.D. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation 2007, 115:3165-3172.
38. Stamm C., Kleine H.D., Choi Y.H., Dunkelmann S., Lauffs J.A., Lorenzen B., David A., Liebold A., Nienaber C., Zurakowski D., Freund M., Steinhoff G. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J. Thorac. Cardiovasc. Surg. 2007, 133:717-725.
39. Yerebakan C., Kaminski A., Westphal B., Donndorf P., Glass A., Liebold A., Stamm C., Steinhoff G. Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133(+) bone marrow stem cell transplant. J. Thorac. Cardiovasc. Surg. 2011, 142:1530-1539. (e1533).
40. Urbich C., Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 2004, 95:343-353.
41. Hur J., Yoon C.H., Kim H.S., Choi J.H., Kang H.J., Hwang K.K., Oh B.H., Lee M.M., Park Y.B. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vasc. Biol. 2004, 24:288-293.
42. Krankel N., Luscher T.F., Landmesser U. "Endothelial progenitor cells" as a therapeutic strategy in cardiovascular disease. Curr. Vasc. Pharmacol. 2012, 10:107-124.
43. Gruh I., Beilner J., Blomer U., Schmiedl A., Schmidt-Richter I., Kruse M.L., Haverich A., Martin U. No evidence of transdifferentiation of human endothelial progenitor cells into cardiomyocytes after coculture with neonatal rat cardiomyocytes. Circulation 2006, 113:1326-1334.
44. Giannotti G., Doerries C., Mocharla P.S., Mueller M.F., Bahlmann F.H., Horvath T., Jiang H., Sorrentino S.A., Steenken N., Manes C., Marzilli M., Rudolph K.L., Luscher T.F., Drexler H., Landmesser U. Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction. Hypertension 2010, 55:1389-1397.
45. Menasche P. Skeletal myoblasts and cardiac repair. J. Mol. Cell. Cardiol. 2008, 45:545-553.
46. Ghostine S., Carrion C., Souza L.C., Richard P., Bruneval P., Vilquin J.T., Pouzet B., Schwartz K., Menasche P., Hagege A.A. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 2002, 106:I131-I136.
47. Hagege A.A., Marolleau J.P., Vilquin J.T., Alheritiere A., Peyrard S., Duboc D., Abergel E., Messas E., Mousseaux E., Schwartz K., Desnos M., Menasche P. Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients. Circulation 2006, 114:I108-I113.
48. Roell W., Lewalter T., Sasse P., Tallini Y.N., Choi B.R., Breitbach M., Doran R., Becher U.M., Hwang S.M., Bostani T., von Maltzahn J., Hofmann A., Reining S., Eiberger B., Gabris B., Pfeifer A., Welz A., Willecke K., Salama G., Schrickel J.W., Kotlikoff M.I., Fleischmann B.K. Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 2007, 450:819-824.
49. Menasche P., Alfieri O., Janssens S., McKenna W., Reichenspurner H., Trinquart L., Vilquin J.T., Marolleau J.P., Seymour B., Larghero J., Lake S., Chatellier G., Solomon S., Desnos M., Hagege A.A. The myoblast autologous grafting in ischemic cardiomyopathy (magic) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 2008, 117:1189-1200.
50. Laflamme M.A., Chen K.Y., Naumova A.V., Muskheli V., Fugate J.A., Dupras S.K., Reinecke H., Xu C., Hassanipour M., Police S., O'Sullivan C., Collins L., Chen Y., Minami E., Gill E.A., Ueno S., Yuan C., Gold J., Murry C.E. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 2007, 25:1015-1024.
51. Yang Y., Min J.Y., Rana J.S., Ke Q., Cai J., Chen Y., Morgan J.P., Xiao Y.F. VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells. J. Appl. Physiol. 2002, 93:1140-1151.
52. Nussbaum J., Minami E., Laflamme M.A., Virag J.A., Ware C.B., Masino A., Muskheli V., Pabon L., Reinecke H., Murry C.E. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J. 2007, 21:1345-1357.
53. Murry C.E., Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 2008, 132:661-680.
54. Nakagawa M., Koyanagi M., Tanabe K., Takahashi K., Ichisaka T., Aoi T., Okita K., Mochiduki Y., Takizawa N., Yamanaka S. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 2008, 26:101-106.
55. Park I.H., Zhao R., West J.A., Yabuuchi A., Huo H., Ince T.A., Lerou P.H., Lensch M.W., Daley G.Q. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008, 451:141-146.
56. Yamanaka S. Induction of pluripotent stem cells from mouse fibroblasts by four transcription factors. Cell Prolif. 2008, 41(Suppl. 1):51-56.
57. Bellin M., Marchetto M.C., Gage F.H., Mummery C.L. Induced pluripotent stem cells: the new patient?. Nat. Rev. Mol. Cell Biol. 2012, 13:713-726.
58. Singla D.K., Long X., Glass C., Singla R.D., Yan B. Induced pluripotent stem (iPS) cells repair and regenerate infarcted myocardium. Mol. Pharm. Oct. 3 2011, 8(5):1573-1581.
59. Kawamura M., Miyagawa S., Miki K., Saito A., Fukushima S., Higuchi T., Kawamura T., Kuratani T., Daimon T., Shimizu T., Okano T., Sawa Y. Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 2012, 126:S29-S37.
60. Kim D., Kim C.H., Moon J.I., Chung Y.G., Chang M.Y., Han B.S., Ko S., Yang E., Cha K.Y., Lanza R., Kim K.S. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009, 4:472-476.
61. Lister R., Pelizzola M., Kida Y.S., Hawkins R.D., Nery J.R., Hon G., Antosiewicz-Bourget J., O'Malley R., Castanon R., Klugman S., Downes M., Yu R., Stewart R., Ren B., Thomson J.A., Evans R.M., Ecker J.R. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011, 471:68-73.
62. Qian L., Huang Y., Spencer C.I., Foley A., Vedantham V., Liu L., Conway S.J., Fu J.D., Srivastava D. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012, 485:593-598.
63. Emmert M.Y., Emmert L.S., Martens A., Ismail I., Schmidt-Richter I., Gawol A., Seifert B., Haverich A., Martin U., Gruh I. Higher frequencies of BCRP+ cardiac resident cells in ischaemic human myocardium. Eur. Heart J. Sep. 2013, 34(36):2830-2838.
64. Oyama T., Nagai T., Wada H., Naito A.T., Matsuura K., Iwanaga K., Takahashi T., Goto M., Mikami Y., Yasuda N., Akazawa H., Uezumi A., Takeda S., Komuro I. Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo. J. Cell Biol. 2007, 176:329-341.
65. Anversa P., Kajstura J., Leri A., Bolli R. Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation 2006, 113:1451-1463.
66. Bearzi C., Rota M., Hosoda T., Tillmanns J., Nascimbene A., De Angelis A., Yasuzawa-Amano S., Trofimova I., Siggins R.W., Lecapitaine N., Cascapera S., Beltrami A.P., D'Alessandro D.A., Zias E., Quaini F., Urbanek K., Michler R.E., Bolli R., Kajstura J., Leri A., Anversa P. Human cardiac stem cells. Proc. Natl. Acad. Sci. U. S. A. Aug. 28 2007, 104(35):14068-14073.
67. Beltrami A.P., Barlucchi L., Torella D., Baker M., Limana F., Chimenti S., Kasahara H., Rota M., Musso E., Urbanek K., Leri A., Kajstura J., Nadal-Ginard B., Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003, 114:763-776.
68. Beltrami A.P., Urbanek K., Kajstura J., Yan S.M., Finato N., Bussani R., Nadal-Ginard B., Silvestri F., Leri A., Beltrami C.A., Anversa P. Evidence that human cardiac myocytes divide after myocardial infarction. N. Engl. J. Med. 2001, 344:1750-1757.
69. Messina E., De Angelis L., Frati G., Morrone S., Chimenti S., Fiordaliso F., Salio M., Battaglia M., Latronico M.V., Coletta M., Vivarelli E., Frati L., Cossu G., Giacomello A. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res. 2004, 95:911-921.
70. Ott H.C., Matthiesen T.S., Brechtken J., Grindle S., Goh S.K., Nelson W., Taylor D.A. The adult human heart as a source for stem cells: repair strategies with embryonic-like progenitor cells. Nat. Clin. Pract. Cardiovasc. Med. 2007, 4(Suppl. 1):S27-S39.
71. Laugwitz K.L., Moretti A., Lam J., Gruber P., Chen Y., Woodard S., Lin L.Z., Cai C.L., Lu M.M., Reth M., Platoshyn O., Yuan J.X., Evans S., Chien K.R. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 2005, 433:647-653.
72. Bolli R., Chugh A.R., D'Amario D., Loughran J.H., Stoddard M.F., Ikram S., Beache G.M., Wagner S.G., Leri A., Hosoda T., Sanada F., Elmore J.B., Goichberg P., Cappetta D., Solankhi N.K., Fahsah I., Rokosh D.G., Slaughter M.S., Kajstura J., Anversa P. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 2011, 378:1847-1857.
73. Makkar R.R., Smith R.R., Cheng K., Malliaras K., Thomson L.E., Berman D., Czer L.S., Marban L., Mendizabal A., Johnston P.V., Russell S.D., Schuleri K.H., Lardo A.C., Gerstenblith G., Marban E. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (caduceus): a prospective, randomised phase 1 trial. Lancet 2012, 379:895-904.
74. Asahara T., Kawamoto A. Endothelial progenitor cells for postnatal vasculogenesis. Am. J. Physiol. Cell Physiol. 2004, 287:C572-C579.
75. Balsam L.B., Wagers A.J., Christensen J.L., Kofidis T., Weissman I.L., Robbins R.C. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004, 428:668-673.
76. Haase A., Olmer R., Schwanke K., Wunderlich S., Merkert S., Hess C., Zweigerdt R., Gruh I., Meyer J., Wagner S., Maier L.S., Han D.W., Glage S., Miller K., Fischer P., Scholer H.R., Martin U. Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell 2009, 5:434-441.
77. Kehat I., Khimovich L., Caspi O., Gepstein A., Shofti R., Arbel G., Huber I., Satin J., Itskovitz-Eldor J., Gepstein L. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat. Biotechnol. 2004, 22:1282-1289.
78. Makino S., Fukuda K., Miyoshi S., Konishi F., Kodama H., Pan J., Sano M., Takahashi T., Hori S., Abe H., Hata J., Umezawa A., Ogawa S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 1999, 103:697-705.
79. Mauritz C., Schwanke K., Reppel M., Neef S., Katsirntaki K., Maier L.S., Nguemo F., Menke S., Haustein M., Hescheler J., Hasenfuss G., Martin U. Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 2008, 118:507-517.
80. Menasche P. Myoblast transplantation: feasibility, safety and efficacy. Ann. Med. 2002, 34:314-315.
81. Pfister O., Mouquet F., Jain M., Summer R., Helmes M., Fine A., Colucci W.S., Liao R. CD31- but not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ. Res. 2005, 97:52-61.
82. Zhou S., Schuetz J.D., Bunting K.D., Colapietro A.M., Sampath J., Morris J.J., Lagutina I., Grosveld G.C., Osawa M., Nakauchi H., Sorrentino B.P. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 2001, 7:1028-1034.
83. Scharenberg C.W., Harkey M.A., Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 2002, 99:507-512.
84. van der Spoel T.I., Jansen of Lorkeers S.J., Agostoni P., van Belle E., Gyongyosi M., Sluijter J.P., Cramer M.J., Doevendans P.A., Chamuleau S.A. Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease. Cardiovasc. Res. 2011, 91:649-658.
85. Mias C., Lairez O., Trouche E., Roncalli J., Calise D., Seguelas M.H., Ordener C., Piercecchi-Marti M.D., Auge N., Salvayre A.N., Bourin P., Parini A., Cussac D. Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. Stem Cells 2009, 27:2734-2743.
86. Godier-Furnemont A.F., Martens T.P., Koeckert M.S., Wan L., Parks J., Arai K., Zhang G., Hudson B., Homma S., Vunjak-Novakovic G. Composite scaffold provides a cell delivery platform for cardiovascular repair. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:7974-7979.
87. Lian W.S., Cheng W.T., Cheng C.C., Hsiao F.S., Chen J.J., Cheng C.F., Wu S.C. In vivo therapy of myocardial infarction with mesenchymal stem cells modified with prostaglandin I synthase gene improves cardiac performance in mice. Life Sci. 2011, 88:455-464.
88. Gnecchi M., He H., Liang O.D., Melo L.G., Morello F., Mu H., Noiseux N., Zhang L., Pratt R.E., Ingwall J.S., Dzau V.J. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med. 2005, 11:367-368.
89. Amado L.C., Saliaris A.P., Schuleri K.H., St John M., Xie J.S., Cattaneo S., Durand D.J., Fitton T., Kuang J.Q., Stewart G., Lehrke S., Baumgartner W.W., Martin B.J., Heldman A.W., Hare J.M. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:11474-11479.
90. Bel A., Messas E., Agbulut O., Richard P., Samuel J.L., Bruneval P., Hagege A.A., Menasche P. Transplantation of autologous fresh bone marrow into infarcted myocardium: a word of caution. Circulation 2003, 108(Suppl. 1):II247-II252.
91. de Silva R., Raval A.N., Hadi M., Gildea K.M., Bonifacino A.C., Yu Z.X., Yau Y.Y., Leitman S.F., Bacharach S.L., Donahue R.E., Read E.J., Lederman R.J. Intracoronary infusion of autologous mononuclear cells from bone marrow or granulocyte colony-stimulating factor-mobilized apheresis product may not improve remodelling, contractile function, perfusion, or infarct size in a swine model of large myocardial infarction. Eur. Heart J. 2008, 29:1772-1782.
92. Brasselet C., Morichetti M.C., Messas E., Carrion C., Bissery A., Bruneval P., Vilquin J.T., Lafont A., Hagege A.A., Menasche P., Desnos M. Skeletal myoblast transplantation through a catheter-based coronary sinus approach: an effective means of improving function of infarcted myocardium. Eur. Heart J. 2005, 26:1551-1556.
93. Messas E., Bel A., Morichetti M.C., Carrion C., Handschumacher M.D., Peyrard S., Vilquin J.T., Desnos M., Bruneval P., Carpentier A., Menasche P., Levine R.A., Hagege A.A. Autologous myoblast transplantation for chronic ischemic mitral regurgitation. J. Am. Coll. Cardiol. 2006, 47:2086-2093.
94. Johnston P.V., Sasano T., Mills K., Evers R., Lee S.T., Smith R.R., Lardo A.C., Lai S., Steenbergen C., Gerstenblith G., Lange R., Marban E. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation 2009, 120:1075-1083. (1077 p. following 1083).
95. Menard C., Hagege A.A., Agbulut O., Barro M., Morichetti M.C., Brasselet C., Bel A., Messas E., Bissery A., Bruneval P., Desnos M., Puceat M., Menasche P. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet 2005, 366:1005-1012.
96. Templin C., Zweigerdt R., Schwanke K., Olmer R., Ghadri J.R., Emmert M.Y., Müller E., Küest S.M., Cohrs S., Schibli R., Kronen P., Hilbe M., Strunk D., Haverich A., Hoerstrup S.P., Lüscher T.F., Kaufmann P.A., Landmesser U., Martin U. Transplantation and tracking of human induced pluripotent stem cells in a pig model of myocardial infarction: assessment of cell survival, engraftment and distribution by hybrid spect-ct imaging of sodium iodide symporter trangene expression. Circulation Jul. 24 2012, 126(4):430-439.
97. Gyongyosi M., Blanco J., Marian T., Tron L., Petnehazy O., Petrasi Z., Hemetsberger R., Rodriguez J., Font G., Pavo I.J., Kertesz I., Balkay L., Pavo N., Posa A., Emri M., Galuska L., Kraitchman D.L., Wojta J., Huber K., Glogar D. Serial noninvasive in vivo positron emission tomographic tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression. Circ. Cardiovasc. Imaging 2008, 1:94-103.
98. Barron V., Lyons E., Stenson-Cox C., McHugh P.E., Pandit A. Bioreactors for cardiovascular cell and tissue growth: a review. Ann. Biomed. Eng. 2003, 31:1017-1030.
99. Govoni M., Muscari C., Guarnieri C., Giordano E. Mechanostimulation protocols for cardiac tissue engineering. BioMed. Res. Int. 2013, 2013:918640.
100. Martin I., Wendt D., Heberer M. The role of bioreactors in tissue engineering. Trends Biotechnol. 2004, 22:80-86.
101. Massai D., Cerino G., Gallo D., Pennella F., Deriu M.A., Rodriguez A., Montevecchi F.M., Bignardi C., Audenino A., Morbiducci U. Bioreactors as engineering support to treat cardiac muscle and vascular disease. J. Healthc. Eng. 2013, 4:329-370.
102. Sotiropoulou P.A., Perez S.A., Salagianni M., Baxevanis C.N., Papamichail M. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 2006, 24:462-471.
103. Sekiya I., Larson B.L., Smith J.R., Pochampally R., Cui J.G., Prockop D.J. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 2002, 20:530-541.
104. Ksiazek K. A comprehensive review on mesenchymal stem cell growth and senescence. Rejuvenation Res. 2009, 12:105-116.
105. Dos Santos F., Andrade P.Z., Boura J.S., Abecasis M.M., da Silva C.L., Cabral J.M. Ex vivo expansion of human mesenchymal stem cells: a more effective cell proliferation kinetics and metabolism under hypoxia. J. Cell. Physiol. 2010, 223:27-35.
106. Godara P., McFarland C.D., Nordon R.E. Design of bioreactors for mesenchymal stem cell tissue engineering. J. Chem. Technol. Biotechnol. 2008, 83:408-420.
107. Frith J.E., Thomson B., Genever P.G. Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential. Tissue Eng. Part C Methods 2010, 16:735-749.
108. Hollister S., Wang Y., Wang G., Chen L., Li H., Yin T., Wang B., Lee J., Yu Q., Kim J. Scaffold Engineering: A Bridge to Where? 2009.
109. Eschenhagen T., Zimmermann W.H. Engineering myocardial tissue. Circ. Res. 2005, 97:1220-1231.
110. Naito H., Melnychenko I., Didie M., Schneiderbanger K., Schubert P., Rosenkranz S., Eschenhagen T., Zimmermann W.H. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation 2006, 114:I72-I78.
111. Zimmermann W.H., Cesnjevar R. Cardiac tissue engineering: implications for pediatric heart surgery. Pediatr. Cardiol. 2009, 30:716-723.
112. Masuda S., Shimizu T., Yamato M., Okano T. Cell sheet engineering for heart tissue repair. Adv. Drug Deliv. Rev. 2008, 60:277-285.
113. Doshi J., Reneker D. Electrospinning process and applications of electrospun fibers. J. Electrost. 1995, 35:151-160.
114. Reneker D., Yarin A. Electrospinning jets and polymer nanofibers. Polymer 2008, 49:2387-2425.
115. Huang Z., Zhang Y., Kotaki M., Ramakrishna S. A review on polymer nanofibers by electrospinning and their applications in nanocomposites. Compos. Sci. Technol. 2003, 63:2223-2253.
116. Baker B.M., Gee A.O., Metter R.B., Nathan A.S., Marklein R.A., Burdick J.A., Mauck R.L. The potential to improve cell infiltration in composite fiber-aligned electrospun scaffolds by the selective removal of sacrificial fibers. Biomaterials 2008, 29:2348-2358.
117. Rowlands A.S., Lim S.A., Martin D., Cooper-White J.J. Polyurethane/poly(lactic-co-glycolic) acid composite scaffolds fabricated by thermally induced phase separation. Biomaterials 2007, 28:2109-2121.
118. Fromstein J.D., Zandstra P.W., Alperin C., Rockwood D., Rabolt J.F., Woodhouse K.A. Seeding bioreactor-produced embryonic stem cell-derived cardiomyocytes on different porous, degradable, polyurethane scaffolds reveals the effect of scaffold architecture on cell morphology. Tissue Eng. Part A 2008, 14:369-378.
119. Khorasani M.T., Shorgashti S. Fabrication of microporous polyurethane by spray phase inversion method as small diameter vascular grafts material. J. Biomed. Mater. Res. A 2006, 77:253-260.
120. Papenburg B.J., Vogelaar L., Bolhuis-Versteeg L.A.M., Lammertink R.G.H., Stamatialis D., Wessling M. One-step fabrication of porous micropatterned scaffolds to control cell behavior. Biomaterials 2007, 28:1998-2009.
121. Papenburg B.J., Liu J., Higuera G.A., Barradas A.M., de Boer J., van Blitterswijk C.A., Wessling M., Stamatialis D. Development and analysis of multi-layer scaffolds for tissue engineering. Biomaterials 2009, 30:6228-6239.
122. Kennedy J.P., McCandless S.P., Rauf A., Williams L.M., Hillam J., Hitchcock R.W. Engineered channels enhance cellular density in perfused scaffolds. Acta Biomater. 2011, 7:3896-3904.
123. Bursac N., Parker K.K., Iravanian S., Tung L. Cardiomyocyte cultures with controlled macroscopic anisotropy: a model for functional electrophysiological studies of cardiac muscle. Circ. Res. 2002, 91:e45-e54.
124. Pong T., Adams W.J., Bray M.A., Feinberg A.W., Sheehy S.P., Werdich A.A., Parker K.K. Hierarchical architecture influences calcium dynamics in engineered cardiac muscle. Exp. Biol. Med. (Maywood) 2011, 236:366-373.
125. Galie P.A., Westfall M.V., Stegemann J.P. Reduced serum content and increased matrix stiffness promote the cardiac myofibroblast transition in 3D collagen matrices. Cardiovasc. Pathol. 2011, 20(6):325-333.
126. Marsano A., Maidhof R., Wan L.Q., Wang Y., Gao J., Tandon N., Vunjak-Novakovic G. Scaffold stiffness affects the contractile function of three-dimensional engineered cardiac constructs. Biotechnol. Prog. 2010, 26:1382-1390.
127. Moroni L., de Wijn J.R., van Blitterswijk C.A. 3D fiber-deposited scaffolds for tissue engineering: influence of pores geometry and architecture on dynamic mechanical properties. Biomaterials 2006, 27:974-985.
128. Kennedy J.P., McCandless S.P., Lasher R.A., Hitchcock R.W. The mechanically enhanced phase separation of sprayed polyurethane scaffolds and their effect on the alignment of fibroblasts. Biomaterials 2010, 31:1126-1132.
129. Liu C., Abedian R., Meister R., Haasper C., Hurschler C., Krettek C., von Lewinski G., Jagodzinski M. Influence of perfusion and compression on the proliferation and differentiation of bone mesenchymal stromal cells seeded on polyurethane scaffolds. Biomaterials 2011, 33:1052-1064.
130. Maidhof R., Tandon N., Lee E.J., Luo J., Duan Y., Yeager K., Konofagou E., Vunjak-Novakovic G. Biomimetic perfusion and electrical stimulation applied in concert improved the assembly of engineered cardiac tissue. J. Tissue Eng. Regen. Med. 2012, 6(10):e12-e23.
131. Zhang T., Wan L.Q., Xiong Z., Marsano A., Maidhof R., Park M., Yan Y., Vunjak-Novakovic G. Channelled scaffolds for engineering myocardium with mechanical stimulation. J. Tissue Eng. Regen. Med. 2011, [Epub ahead of print]. 10.1002/term.481.
132. Maidhof R., Marsano A., Lee E.J., Vunjak-Novakovic G. Perfusion seeding of channeled elastomeric scaffolds with myocytes and endothelial cells for cardiac tissue engineering. Biotechnol. Prog. 2010, 26:565-572.
133. Kaihara S., Borenstein J., Koka R., Lalan S., Ochoa E., Ravens M., Pien H., Cunningham B., Vacanti J. Silicon micromachining to tissue engineer branched vascular channels for liver fabrication. Tissue Eng. 2000, 6:105-117.
134. Papenburg B.J., Bolhuis-Versteeg L.A., Grijpma D.W., Feijen J., Wessling M., Stamatialis D. A facile method to fabricate poly(l-lactide) nano-fibrous morphologies by phase inversion. Acta Biomater. 2010, 6(7):2477-2483.
135. Fink C., Ergun S., Kralisch D., Remmers U., Weil J., Eschenhagen T. Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. FASEB J. 2000, 14:669-679.
136. Zimmermann W.H., Schneiderbanger K., Schubert P., Didie M., Munzel F., Heubach J.F., Kostin S., Neuhuber W.L., Eschenhagen T. Tissue engineering of a differentiated cardiac muscle construct. Circ. Res. 2002, 90:223-230.
137. Feng Z., Matsumoto T., Nomura Y., Nakamura T. An electro-tensile bioreactor for 3D culturing of cardiomyocytes. IEEE Eng. Med. Biol. Mag. 2005, 24:73-79.
138. Radisic M., Park H., Shing H., Consi T., Schoen F.J., Langer R., Freed L.E., Vunjak-Novakovic G. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:18129-18134.
139. Tandon N., Cannizzaro C., Chao P.H.G., Maidhof R., Marsano A., Au H.T.H., Radisic M., Vunjak-Novakovic G. Electrical stimulation systems for cardiac tissue engineering. Nat. Protoc. 2009, 4:155-173.
140. Cannizzaro C., Tandon N., Figallo E., Park H., Gerecht S., Radisic M., Elvassore N., Vunjak-Novakovic G. Practical aspects of cardiac tissue engineering with electrical stimulation. Methods Mol. Med. 2007, 140:291-307.
141. Akhyari P., Fedak P.W.M., Weisel R.D., Lee T.Y.J., Verma S., Mickle D.A.G., Li R.K. Mechanical stretch regimen enhances the formation of bioengineered autologous cardiac muscle grafts 2002, 106:137-142.
142. Birla R.K., Huang Y.C., Dennis R.G. Development of a novel bioreactor for the mechanical loading of tissue-engineered heart muscle. Tissue Eng. 2007, 13:2239-2248.
143. Zhuang J., Yamada K.A., Saffitz J.E., Kleber A.G. Pulsatile stretch remodels cell-to-cell communication in cultured myocytes. Circ. Res. 2000, 87:316-322.
144. Gonen-Wadmany M., Gepstein L., Seliktar D. Controlling the cellular organization of tissue-engineered cardiac constructs. Ann. N. Y. Acad. Sci. 2004, 1015:299-311.
145. Radisic M., Fast V.G., Sharifov O.F., Iyer R.K., Park H., Vunjak-Novakovic G. Optical mapping of impulse propagation in engineered cardiac tissue. Tissue Eng. Part A 2009, 15:851-860.
146. Radisic M., Park H., Gerecht S., Cannizzaro C., Langer R., Vunjak-Novakovic G. Biomimetic approach to cardiac tissue engineering. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2007, 362:1357-1368.
147. Griffith L.G., Naughton G. Tissue engineering-current challenges and expanding opportunities. Science 2002, 295:1009-1014.
148. Eschenhagen T., Fink C., Remmers U., Scholz H., Wattchow J., Weil J., Zimmermann W., Dohmen H.H., Schafer H., Bishopric N., Wakatsuki T., Elson E.L. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J. 1997, 11:683-694.
149. Christman K.L., Lee R.J. Biomaterials for the treatment of myocardial infarction. J. Am. Coll. Cardiol. 2006, 48:907-913.
150. Dvir T., Kedem A., Ruvinov E., Levy O., Freeman I., Landa N., Holbova R., Feinberg M.S., Dror S., Etzion Y., Leor J., Cohen S. Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:14990-14995.
151. Iyer R.K., Chiu L.L., Reis L.A., Radisic M. Engineered cardiac tissues. Curr. Opin. Biotechnol. 2011, 22:706-714.
152. Nawroth J.C., Lee H., Feinberg A.W., Ripplinger C.M., McCain M.L., Grosberg A., Dabiri J.O., Parker K.K. A tissue-engineered jellyfish with biomimetic propulsion. Nat. Biotechnol. 2012, 30:792-797.
153. Caspi O., Lesman A., Basevitch Y., Gepstein A., Arbel G., Habib I.H., Gepstein L., Levenberg S. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ. Res. 2007, 100:263-272.
154. Bhana B., Iyer R.K., Chen W.L., Zhao R., Sider K.L., Likhitpanichkul M., Simmons C.A., Radisic M. Influence of substrate stiffness on the phenotype of heart cells. Biotechnol. Bioeng. 2010, 105:1148-1160.
155. Jacot J.G., McCulloch A.D., Omens J.H. Substrate stiffness affects the functional maturation of neonatal rat ventricular myocytes. Biophys. J. 2008, 95:3479-3487.
156. Miyagawa S., Sawa Y., Sakakida S., Taketani S., Kondoh H., Memon I.A., Imanishi Y., Shimizu T., Okano T., Matsuda H. Tissue cardiomyoplasty using bioengineered contractile cardiomyocyte sheets to repair damaged myocardium: their integration with recipient myocardium. Transplantation 2005, 80:1586-1595.
157. Zimmermann W.H., Melnychenko I., Wasmeier G., Didie M., Naito H., Nixdorff U., Hess A., Budinsky L., Brune K., Michaelis B., Dhein S., Schwoerer A., Ehmke H., Eschenhagen T. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat. Med. 2006, 12:452-458.
158. Xue T., Cho H.C., Akar F.G., Tsang S.Y., Jones S.P., Marban E., Tomaselli G.F., Li R.A. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation 2005, 111:11-20.
159. Kraehenbuehl T.P., Ferreira L.S., Hayward A.M., Nahrendorf M., van der Vlies A.J., Vasile E., Weissleder R., Langer R., Hubbell J.A. Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction. Biomaterials 2011, 32:1102-1109.
160. Leung B.M., Sefton M.V. A modular approach to cardiac tissue engineering. Tissue Eng. Part A 2010, 16:3207-3218.
161. Miyagi Y., Chiu L.L., Cimini M., Weisel R.D., Radisic M., Li R.K. Biodegradable collagen patch with covalently immobilized VEGF for myocardial repair. Biomaterials 2011, 32:1280-1290.
162. Barandon L., Couffinhal T., Dufourcq P., Alzieu P., Daret D., Deville C., Duplaa C. Repair of myocardial infarction by epicardial deposition of bone-marrow-cell-coated muscle patch in a murine model. Ann. Thorac. Surg. 2004, 78:1409-1417.
163. Chen C.H., Wei H.J., Lin W.W., Chiu I., Hwang S.M., Wang C.C., Lee W.Y., Chang Y., Sung H.W. Porous tissue grafts sandwiched with multilayered mesenchymal stromal cell sheets induce tissue regeneration for cardiac repair. Cardiovasc. Res. 2008, 80:88-95.
164. Wei H.J., Chen S.C., Chang Y., Hwang S.M., Lin W.W., Lai P.H., Chiang H.K., Hsu L.F., Yang H.H., Sung H.W. Porous acellular bovine pericardia seeded with mesenchymal stem cells as a patch to repair a myocardial defect in a syngeneic rat model. Biomaterials 2006, 27:5409-5419.
165. Jin J., Jeong S.I., Shin Y.M., Lim K.S., Shin H., Lee Y.M., Koh H.C., Kim K.S. Transplantation of mesenchymal stem cells within a poly(lactide-co-epsilon-caprolactone) scaffold improves cardiac function in a rat myocardial infarction model. Eur. J. Heart Fail. 2009, 11:147-153.
166. Simpson D., Liu H., Fan T.H., Nerem R., Dudley S.C. A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling. Stem Cells 2007, 25:2350-2357.
167. Tan M.Y., Zhi W., Wei R.Q., Huang Y.C., Zhou K.P., Tan B., Deng L., Luo J.C., Li X.Q., Xie H.Q., Yang Z.M. Repair of infarcted myocardium using mesenchymal stem cell seeded small intestinal submucosa in rabbits. Biomaterials 2009, 30:3234-3240.
168. Miyahara Y., Nagaya N., Kataoka M., Yanagawa B., Tanaka K., Hao H., Ishino K., Ishida H., Shimizu T., Kangawa K., Sano S., Okano T., Kitamura S., Mori H. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat. Med. 2006, 12:459-465.
169. Zakharova L., Mastroeni D., Mutlu N., Molina M., Goldman S., Diethrich E., Gaballa M.A. Transplantation of cardiac progenitor cell sheet onto infarcted heart promotes cardiogenesis and improves function. Cardiovasc. Res. 2010, 87:40-49.
170. Kofidis T., Lebl D.R., Martinez E.C., Hoyt G., Tanaka M., Robbins R.C. Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Circulation 2005, 112:I173-I177.
171. Lin Y.D., Yeh M.L., Yang Y.J., Tsai D.C., Chu T.Y., Shih Y.Y., Chang M.Y., Liu Y.W., Tang A.C., Chen T.Y., Luo C.Y., Chang K.C., Chen J.H., Wu H.L., Hung T.K., Hsieh P.C. Intramyocardial peptide nanofiber injection improves postinfarction ventricular remodeling and efficacy of bone marrow cell therapy in pigs. Circulation 2010, 122:S132-S141.
172. Wall S.T., Yeh C.C., Tu R.Y., Mann M.J., Healy K.E. Biomimetic matrices for myocardial stabilization and stem cell transplantation. J. Biomed. Mater. Res. A 2010, 95:1055-1066.
173. Wang T., Jiang X.J., Tang Q.Z., Li X.Y., Lin T., Wu D.Q., Zhang X.Z., Okello E. Bone marrow stem cells implantation with alpha-cyclodextrin/MPEG-PCL-MPEG hydrogel improves cardiac function after myocardial infarction. Acta Biomater. 2009, 5:2939-2944.
174. Dai W., Hale S.L., Kay G.L., Jyrala A.J., Kloner R.A. Delivering stem cells to the heart in a collagen matrix reduces relocation of cells to other organs as assessed by nanoparticle technology. Regen. Med. 2009, 4:387-395.
175. Christman K.L., Fok H.H., Sievers R.E., Fang Q., Lee R.J. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng. 2004, 10:403-409.
176. Danoviz M.E., Nakamuta J.S., Marques F.L., dos Santos L., Alvarenga E.C., dos Santos A.A., Antonio E.L., Schettert I.T., Tucci P.J., Krieger J.E. Rat adipose tissue-derived stem cells transplantation attenuates cardiac dysfunction post infarction and biopolymers enhance cell retention. PLoS One 2010, 5:e12077.
177. Guo H.D., Wang H.J., Tan Y.Z., Wu J.H. Transplantation of marrow-derived cardiac stem cells carried in fibrin improves cardiac function after myocardial infarction. Tissue Eng. Part A 2011, 17:45-58.
178. Nakamuta J.S., Danoviz M.E., Marques F.L., dos Santos L., Becker C., Goncalves G.A., Vassallo P.F., Schettert I.T., Tucci P.J., Krieger J.E. Cell therapy attenuates cardiac dysfunction post myocardial infarction: effect of timing, routes of injection and a fibrin scaffold. PLoS One 2009, 4:e6005.
179. Wang C.C., Chen C.H., Lin W.W., Hwang S.M., Hsieh P.C., Lai P.H., Yeh Y.C., Chang Y., Sung H.W. Direct intramyocardial injection of mesenchymal stem cell sheet fragments improves cardiac functions after infarction. Cardiovasc. Res. 2008, 77:515-524.
180. Martens T.P., Godier A.F., Parks J.J., Wan L.Q., Koeckert M.S., Eng G.M., Hudson B.I., Sherman W., Vunjak-Novakovic G. Percutaneous cell delivery into the heart using hydrogels polymerizing in situ. Cell Transplant. 2009, 18:297-304.
181. Radisic M., Christman K.L. Materials science and tissue engineering: repairing the heart. Mayo Clin. Proc. 2013, 88:884-898.
182. Landa N., Miller L., Feinberg M.S., Holbova R., Shachar M., Freeman I., Cohen S., Leor J. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation 2008, 117:1388-1396.
183. Leor J., Tuvia S., Guetta V., Manczur F., Castel D., Willenz U., Petnehazy O., Landa N., Feinberg M.S., Konen E., Goitein O., Tsur-Gang O., Shaul M., Klapper L., Cohen S. Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in swine. J. Am. Coll. Cardiol. 2009, 54:1014-1023.
184. Bartosh T.J., Ylostalo J.H., Mohammadipoor A., Bazhanov N., Coble K., Claypool K., Lee R.H., Choi H., Prockop D.J. Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:13724-13729.
185. Garzoni L.R., Rossi M.I., de Barros A.P., Guarani V., Keramidas M., Balottin L.B., Adesse D., Takiya C.M., Manso P.P., Otazu I.B., Meirelles Mde N., Borojevic R. Dissecting coronary angiogenesis: 3D co-culture of cardiomyocytes with endothelial or mesenchymal cells. Exp. Cell Res. 2009, 315:3406-3418.
186. Kelm J.M., Diaz Sanchez-Bustamante C., Ehler E., Hoerstrup S.P., Djonov V., Ittner L., Fussenegger M. VEGF profiling and angiogenesis in human microtissues. J. Biotechnol. 2005, 118:213-229.
187. Kelm J.M., Djonov V., Ittner L.M., Fluri D., Born W., Hoerstrup S.P., Fussenegger M. Design of custom-shaped vascularized tissues using microtissue spheroids as minimal building units. Tissue Eng. 2006, 12:2151-2160.
188. Kelm J.M., Fussenegger M. Microscale tissue engineering using gravity-enforced cell assembly. Trends Biotechnol. 2004, 22:195-202.
189. Wang W., Itaka K., Ohba S., Nishiyama N., Chung U.I., Yamasaki Y., Kataoka K. 3D spheroid culture system on micropatterned substrates for improved differentiation efficiency of multipotent mesenchymal stem cells. Biomaterials 2009, 30:2705-2715.
190. Kelm J.M., Djonov V., Hoerstrup S.P., Guenter C.I., Ittner L.M., Greve F., Hierlemann A., Sanchez-Bustamante C.D., Perriard J.C., Ehler E., Fussenegger M. Tissue-transplant fusion and vascularization of myocardial microtissues and macrotissues implanted into chicken embryos and rats. Tissue Eng. 2006, 12:2541-2553.
191. Emmert M.Y., Wolint P., Wickboldt N., Gemayel G., Weber B., Brokopp C.E., Boni A., Falk V., Bosman A., Jaconi M.E., Hoerstrup S.P. Human stem cell-based three-dimensional microtissues for advanced cardiac cell therapies. Biomaterials 2013, 34:6339-6354.
192. Kensah G., Roa Lara A., Dahlmann J., Zweigerdt R., Schwanke K., Hegermann J., Skvorc D., Gawol A., Azizian A., Wagner S., Maier L.S., Krause A., Drager G., Ochs M., Haverich A., Gruh I., Martin U. Murine and human pluripotent stem cell-derived cardiac bodies form contractile myocardial tissue in vitro. Eur. Heart J. 2013, 34(15):1134-1146.
193. Testa U., Pannitteri G., Condorelli G.L. Vascular endothelial growth factors in cardiovascular medicine. J. Cardiovasc. Med. (Hagerstown) 2008, 9:1190-1221.
194. Emmert M.Y., Wolint P., Winklhofer S., Stolzmann P., Cesarovic N., Fleischmann T., Nguyen T.D., Frauenfelder T., Boni R., Scherman J., Bettex D., Grunenfelder J., Schwartlander R., Vogel V., Gyongyosi M., Alkadhi H., Falk V., Hoerstrup S.P. Transcatheter based electromechanical mapping guided intramyocardial transplantation and in vivo tracking of human stem cell based three dimensional microtissues in the porcine heart. Biomaterials 2013, 34:2428-2441.
195. Schachinger V., Erbs S., Elsasser A., Haberbosch W., Hambrecht R., Holschermann H., Yu J., Corti R., Mathey D.G., Hamm C.W., Suselbeck T., Assmus B., Tonn T., Dimmeler S., Zeiher A.M. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med. 2006, 355:1210-1221.
196. Wollert K.C., Meyer G.P., Lotz J., Ringes-Lichtenberg S., Lippolt P., Breidenbach C., Fichtner S., Korte T., Hornig B., Messinger D., Arseniev L., Hertenstein B., Ganser A., Drexler H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004, 364:141-148.
197. Janssens S., Dubois C., Bogaert J., Theunissen K., Deroose C., Desmet W., Kalantzi M., Herbots L., Sinnaeve P., Dens J., Maertens J., Rademakers F., Dymarkowski S., Gheysens O., Van Cleemput J., Bormans G., Nuyts J., Belmans A., Mortelmans L., Boogaerts M., Van de Werf F. Autologous bone marrow-derived stem-cell transfer in patients with st-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006, 367:113-121.
198. Lunde K., Solheim S., Aakhus S., Arnesen H., Abdelnoor M., Egeland T., Endresen K., Ilebekk A., Mangschau A., Fjeld J.G., Smith H.J., Taraldsrud E., Grogaard H.K., Bjornerheim R., Brekke M., Muller C., Hopp E., Ragnarsson A., Brinchmann J.E., Forfang K. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med. 2006, 355:1199-1209.
199. Tendera M., Wojakowski W., Ruzyllo W., Chojnowska L., Kepka C., Tracz W., Musialek P., Piwowarska W., Nessler J., Buszman P., Grajek S., Breborowicz P., Majka M., Ratajczak M.Z. Intracoronary infusion of bone marrow-derived selected CD34+ CXCR4+ cells and non-selected mononuclear cells in patients with acute stemi and reduced left ventricular ejection fraction: results of randomized, multicentre myocardial regeneration by intracoronary infusion of selected population of stem cells in acute myocardial infarction (regent) trial. Eur. Heart J. 2009, 30:1313-1321.
200. Perin E.C., Willerson J.T., Pepine C.J., Henry T.D., Ellis S.G., Zhao D.X., Silva G.V., Lai D., Thomas J.D., Kronenberg M.W., Martin A.D., Anderson R.D., Traverse J.H., Penn M.S., Anwaruddin S., Hatzopoulos A.K., Gee A.P., Taylor D.A., Cogle C.R., Smith D., Westbrook L., Chen J., Handberg E., Olson R.E., Geither C., Bowman S., Francescon J., Baraniuk S., Piller L.B., Simpson L.M., Loghin C., Aguilar D., Richman S., Zierold C., Bettencourt J., Sayre S.L., Vojvodic R.W., Skarlatos S.I., Gordon D.J., Ebert R.F., Kwak M., Moye L.A., Simari R.D., Cardiovascular Cell Therapy Research N Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA 2012, 307:1717-1726.
201. Hirsch A., Nijveldt R., van der Vleuten P.A., Tijssen J.G., van der Giessen W.J., Tio R.A., Waltenberger J., ten Berg J.M., Doevendans P.A., Aengevaeren W.R., Zwaginga J.J., Biemond B.J., van Rossum A.C., Piek J.J., Zijlstra F. Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial. Eur. Heart J. 2011, 32:1736-1747.
202. Surder D., Manka R., Lo Cicero V., Moccetti T., Rufibach K., Soncin S., Turchetto L., Radrizzani M., Astori G., Schwitter J., Erne P., Zuber M., Auf der Maur C., Jamshidi P., Gaemperli O., Windecker S., Moschovitis A., Wahl A., Buhler I., Wyss C., Kozerke S., Landmesser U., Luscher T.F., Corti R. Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function. Circulation 2013, 127:1968-1979.
203. Traverse J.H., Henry T.D., Ellis S.G., Pepine C.J., Willerson J.T., Zhao D.X., Forder J.R., Byrne B.J., Hatzopoulos A.K., Penn M.S., Perin E.C., Baran K.W., Chambers J., Lambert C., Raveendran G., Simon D.I., Vaughan D.E., Simpson L.M., Gee A.P., Taylor D.A., Cogle C.R., Thomas J.D., Silva G.V., Jorgenson B.C., Olson R.E., Bowman S., Francescon J., Geither C., Handberg E., Smith D.X., Baraniuk S., Piller L.B., Loghin C., Aguilar D., Richman S., Zierold C., Bettencourt J., Sayre S.L., Vojvodic R.W., Skarlatos S.I., Gordon D.J., Ebert R.F., Kwak M., Moye L.A., Simari R.D. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LATETIME randomized trial. JAMA 2011, 306:2110-2119.
204. Traverse J.H., Henry T.D., Pepine C.J., Willerson J.T., Zhao D.X., Ellis S.G., Forder J.R., Anderson R.D., Hatzopoulos A.K., Penn M.S., Perin E.C., Chambers J., Baran K.W., Raveendran G., Lambert C., Lerman A., Simon D.I., Vaughan D.E., Lai D., Gee A.P., Taylor D.A., Cogle C.R., Thomas J.D., Olson R.E., Bowman S., Francescon J., Geither C., Handberg E., Kappenman C., Westbrook L., Piller L.B., Simpson L.M., Baraniuk S., Loghin C., Aguilar D., Richman S., Zierold C., Spoon D.B., Bettencourt J., Sayre S.L., Vojvodic R.W., Skarlatos S.I., Gordon D.J., Ebert R.F., Kwak M., Moye L.A., Simari R.D. Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the time randomized trial. JAMA 2012, 308:2380-2389.
205. Psaltis P.J., Zannettino A.C., Worthley S.G., Gronthos S. Concise review: mesenchymal stromal cells: potential for cardiovascular repair. Stem Cells 2008, 26:2201-2210.
206. Chen S.L., Fang W., Ye F., Liu Y.H., Qian J., Shan S., Zhang J., Zhao R.C.H., Liao L.M., Lin S., Sun J.P. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am. J. Cardiol. 2004, 94:92-95.
207. Hare J.M., Fishman J.E., Gerstenblith G., Velazquez D.L.D., Zambrano J.P., Suncion V.Y., Tracy M., Ghersin E., Johnston P.V., Brinker J.A., Breton E., Davis-Sproul J., Schulman I.H., Byrnes J., Mendizabal A.M., Lowery M.H., Rouy D., Altman P., Foo C.W.P., Ruiz P., Amador A., Da Silva J., McNiece I.K., Heldman A.W. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA 2012, 308:2369-2379.
208. Bartunek J., Behfar A., Dolatabadi D., Vanderheyden M., Ostojic M., Dens J., El Nakadi B., Banovic M., Beleslin B., Vrolix M., Legrand V., Vrints C., Vanoverschelde J.L., Crespo-Diaz R., Homsy C., Tendera M., Waldman S., Wijns W., Terzic A. Cardiopoietic stem cell therapy in heart failure: the C-CURE (cardiopoietic stem cell therapy in heart failure) multicenter randomized trial with lineage-specified biologics. J. Am. Coll. Cardiol. 2013, 61:2329-2338.
209. Menasche P. Stem cell therapy for heart failure: are arrhythmias a real safety concern?. Circulation 2009, 119:2735-2740.
210. Chachques J.C., Trainini J.C., Lago N., Cortes-Morichetti M., Schussler O., Carpentier A. Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM trial): clinical feasibility study. Ann. Thorac. Surg. 2008, 85:901-908.
211. Strauer B.E., Steinhoff G. 10years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. J. Am. Coll. Cardiol. 2011, 58:1095-1104.
212. Moreno-Gonzalez A., Korte F.S., Dai J., Chen K., Ho B., Reinecke H., Murry C.E., Regnier M. Cell therapy enhances function of remote non-infarcted myocardium. J. Mol. Cell. Cardiol. 2009, 47:603-613.
213. Chimenti I., Smith R.R., Li T.S., Gerstenblith G., Messina E., Giacomello A., Marban E. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ. Res. 2010, 106:971-980.
214. Hamdi H., Planat-Benard V., Bel A., Puymirat E., Geha R., Pidial L., Nematalla H., Bellamy V., Bouaziz P., Peyrard S., Casteilla L., Bruneval P., Hagege A.A., Agbulut O., Menasche P. Epicardial adipose stem cell sheets results in greater post-infarction survival than intramyocardial injections. Cardiovasc. Res. 2011, 91(3):483-491.
215. Bel A., Planat-Bernard V., Saito A., Bonnevie L., Bellamy V., Sabbah L., Bellabas L., Brinon B., Vanneaux V., Pradeau P., Peyrard S., Larghero J., Pouly J., Binder P., Garcia S., Shimizu T., Sawa Y., Okano T., Bruneval P., Desnos M., Hagege A.A., Casteilla L., Puceat M., Menasche P. Composite cell sheets: a further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells. Circulation 2010, 122:S118-S123.